Location History:
- Erlangen, DE (2006)
- Ulm-Einsingen, DE (2014)
- Ulm, DE (2010 - 2015)
- Hannover, DE (2019)
Company Filing History:
3 out of 6 
1 out of 2 
1 out of 8 Years Active: 2006-2019
Title: Frank Kirchhoff: A Pioneer in Peptide Innovation
Introduction: Frank Kirchhoff is a distinguished inventor based in Ulm, Germany, recognized for his significant contributions to the field of biochemistry and pharmaceutical sciences. With a remarkable portfolio of seven patents, he has made strides in developing peptides that target critical biological processes, particularly in the context of HIV research.
Latest Patents: Among his most recent innovations are two notable patents focusing on peptides with antagonistic activities against the CXC-chemokine receptor 4 (CXCR4). The first patent details a peptide that effectively blocks CXCR4-mediated HIV-1 NL4-3 (X4-tropic) infection, demonstrating an inhibition constant (IC) value of less than 50 µM. The second patent presents a CXC chemokine receptor 4 antagonistic polypeptide, which encompasses a specific amino acid sequence along with its biologically active fragments, variants, and derivatives. These include modifications such as amidation, acetylation, sulfation, phosphorylation, and glycosylation, showcasing the versatility and potential therapeutic applications of his work.
Career Highlights: Frank Kirchhoff has harnessed his expertise through impactful roles at leading pharmaceutical companies, including Ipf Pharmaceuticals GmbH and Pharis Biotech GmbH. His dedication to innovation in peptide technology continues to shape advancements in drug development and therapeutic interventions.
Collaborations: Throughout his career, Kirchhoff has collaborated with esteemed colleagues in the industry, notably Jan Münch and Wolf-Georg Forssmann. These partnerships have fostered a collaborative environment that enhances research quality and propels innovative solutions within the health sector.
Conclusion: Frank Kirchhoff stands out as a remarkable inventor whose work in peptide innovation has the potential to transform therapeutic strategies, particularly in combating viral infections like HIV. His ongoing contributions continue to inspire future research and development in the pharmaceutical industry, underscoring the importance of inventive minds in advancing health sciences.